Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04016584 · ClinicalTrials.gov registry record · NA
Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy
A NA study of Type2 Diabetes, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04016584 is a NA study of Type2 Diabetes that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 25 participants, below the 47,821-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04016584, a NA study of Type2 Diabetes, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently in the United States, the achieved level of glycemic control for adult Latinos with type 2 diabetes (T2D) is sub-optimal compared to the non-Latino Caucasian population. Among Latinos with T2D, there are unique barriers, such as socioeconomic and cultural factors, to starting and optimizing therapies, including insulin. Latinos have cultural beliefs and behaviors specific to this population that should be appropriately addressed in a diabetes self-management education and support program. Diabetes Pueblo is a diabetes education program that may be a solution to help address the barriers Latinos with T2D have to diabetes care and insulin use. The Diabetes Pueblo program consists of two targeted diabetes education curriculums for the local Latino community: (a) Diabetes Fundamentals and (b) Insulin Success, a culturally appropriate program course addressing barriers to initiating and optimizing insulin and T2D therapies. We will explore if Diabetes Pueblo Program improves knowledge of lifestyle advice for healthy eating and physical activity, increase the propensity to use insulin when clinically indicated, and improve success rates with insulin therapy by addressing common fears and negative perceptions of T2D therapies in this population.
Conditions Studied
Interventions
- BEHAVIORAL Diabetes Pueblo
Study Locations (1)
California
- Sansum Diabetes Research Institute - Santa Barbara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2020-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04016584
The ClinicalTrials.gov registry entry for NCT04016584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47,821-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Pueblo is the first listed.
NCT04016584 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04016584 about?
NCT04016584 is a clinical study titled "Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy". Currently in the United States, the achieved level of glycemic control for adult Latinos with type 2 diabetes (T2D) is sub-optimal compared to the non-Latino Caucasian population. Among Latinos with T2D, there are unique barriers, such as socioeconomic and cultural factors, to starting and optimizin...
What is the current status of trial NCT04016584?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-05-10. Estimated completion is 2020-02-25.
What conditions does trial NCT04016584 study?
This clinical trial studies the following conditions: Type2 Diabetes.
What interventions are being tested in trial NCT04016584?
The interventions under investigation include: Diabetes Pueblo (BEHAVIORAL).
Who is sponsoring clinical trial NCT04016584?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04016584 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity
ACTIVE NOT RECRUITING · NA
-
Blueberry Consumption and Type 2 Diabetes
COMPLETED · NA
-
An Emotion-Focused Intervention for Glycemic Control in T2D
COMPLETED · NA
-
Dietary Approaches to Stop Hypertension for Diabetes
COMPLETED · NA
-
Hypoglycemia and Autonomic Nervous System Function- B2
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.